Latest filingSep 08, 2026Most recent Form 4
AQST
Aquestive Therapeutics, Inc.
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 08/09 to 09/09. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$10.7M1 sells
Net open-market-$10.7M3 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period4transactions
- X · Derivative exercise · dominant2 · 50%
- F · Tax withholding1 · 25%
- S · Open-market sells1 · 25%
Activity by reported role
A joint filing can contribute to multiple roles4transactions
- COO · dominant2 · 50%
- CCO1 · 25%
- PRES1 · 25%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (2)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeKorczynski SherryCommon Stock · Direct
235,689Aug 14, 2026
Barber DanielCommon Stock · Direct
585,574Aug 17, 2026
Jung CassieWarrant (Right to Buy) · Direct
0Sep 03, 2026
Jung CassieCommon Stock · Direct
206,833Sep 03, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 09 → Sep 09
LessMore
Top insiders
By absolute net value across the selected period- BD-$107.2k
- KS-$11.5k
- JC+$4.4k
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
AQST transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| AQST | Jung Cassie | COO | exercise | 4.58k | $0 | X | — | 0.0% | 09/08 | 09/03 |
| AQST | Jung Cassie | COO | exercise | 4.58k | $440k | X | — | 0.0% | 09/08 | 09/03 |
| AQST | Barber Daniel | PRES | sale | 25.0k | -$10.7M | S | +21.3% | 08/18 | 08/17 | |
| AQST | Korczynski Sherry | CCO | withholding | 2.71k | -$1.15M | F | +22.1% | 08/17 | 08/14 |
Aquestive Therapeutics, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Aquestive Therapeutics, Inc.?
Jung Cassie, Barber Daniel, Korczynski Sherry.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Barber Daniel reported a sale on Aug 17, 2026 valued at $10.7M. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $107,167.50. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.